Evidence · Review article
Admission Criteria to Paediatric Intensive Care for Oncology Haematology Patients: Updates and Evidence-Based Clinical Recommendations.
- Cardiovascular
- ECMO
- Fluids and electrolytes
- Haematology and oncology
- Infection and sepsis
- Mechanical ventilation
- Medical
- Non-invasive ventilation and high flow
- Nursing
- Oncology emergencies
- PARDS
- Professional practice
- Renal and metabolic
- Renal replacement therapy
- Respiratory
- Sepsis
Summary
A narrative/systematic review proposing an updated, evidence-based framework for deciding when children with haematological malignancies or solid tumours should be admitted to PICU. It integrates recent international guidance including the Phoenix 2024 sepsis criteria and PALICC-2 2023 PARDS recommendations, and reviews outcomes of advanced organ support such as non-invasive respiratory support, ECMO and continuous renal replacement therapy for tumour lysis syndrome. Infection risk stratification with biomarkers (IL-6, IL-10, procalcitonin) is discussed. The authors emphasise early recognition of deterioration, timely non-invasive respiratory support and centralisation of care in networked reference centres.
Summary written for PICUlearn. Always read the original.
- Licence:
- Open (Creative Commons)
The full text of this openly licensed paper is available to PICUlearn members, and Peeky can answer questions from it.
Guidelines are shown for education. Follow your unit's own guidance and senior advice.